Acutaas Chemicals Ltd Hits All-Time High, Marking a Milestone in Market Performance

Record-Breaking Price Movement

On 10 Feb 2026, Acutaas Chemicals Ltd touched an intraday high of Rs.2056.35, marking the highest price level ever recorded for the stock. This milestone was accompanied by a notable day gain of 3.20%, significantly outperforming the Sensex, which rose by only 0.36% on the same day. The stock also outperformed its sector by 1.82%, reflecting strong investor confidence and market momentum.

The stock has demonstrated consistent upward movement, registering gains for three consecutive days with a cumulative return of 3.25% during this period. Trading above all key moving averages — 5-day, 20-day, 50-day, 100-day, and 200-day — further confirms the strength of its current trend.

Long-Term Performance Outshines Benchmarks

Acutaas Chemicals Ltd’s performance over various time horizons has been impressive when compared to benchmark indices. Over the past year, the stock delivered a remarkable 66.06% return, vastly exceeding the Sensex’s 9.13% gain. Year-to-date, the stock has appreciated by 21.25%, while the Sensex declined by 1.00%.

Over three years, the stock’s return stands at an extraordinary 356.83%, dwarfing the Sensex’s 39.03% gain. This sustained outperformance highlights the company’s ability to generate value consistently over the long term. Even in shorter periods such as one month and three months, Acutaas Chemicals Ltd has outpaced the Sensex by delivering returns of 22.34% and 16.88% respectively, compared to the Sensex’s sub-1% gains.

Financial Strength and Growth Metrics

The company’s financial fundamentals underpin its market success. Acutaas Chemicals Ltd maintains a low average Debt to Equity ratio of 0, indicating a debt-free capital structure that reduces financial risk and enhances operational flexibility.

Net sales have grown at an annualised rate of 26.84%, while operating profit has expanded even more robustly at 38.56%. Net profit growth has been particularly strong, rising by 47.82%, with the company declaring outstanding results in December 2025. This marks six consecutive quarters of positive results, signalling consistent operational excellence.

Return on Capital Employed (ROCE) for the half-year period reached a high of 21.30%, reflecting efficient utilisation of capital. Inventory turnover ratio stood at 5.74 times, and debtors turnover ratio was 3.76 times, both indicating effective management of working capital.

Institutional Confidence and Market Recognition

Institutional investors hold a significant 38.38% stake in Acutaas Chemicals Ltd, suggesting strong backing from entities with extensive analytical resources. This level of institutional ownership often correlates with rigorous fundamental analysis and confidence in the company’s prospects.

MarketsMojo ranks Acutaas Chemicals Ltd among the top 1% of over 4,000 stocks analysed, placing it 5th among Small Cap companies and 18th across the entire market. The company’s Mojo Score of 82.0 and an upgraded Mojo Grade of Strong Buy (from Buy on 6 Oct 2025) further attest to its quality and market standing.

Valuation and Profitability Considerations

Despite its strong growth, the company carries a very expensive valuation with a Price to Book Value of 11.6. Its Return on Equity (ROE) stands at 15.8%, reflecting solid profitability. The PEG ratio of 0.4 indicates that the stock’s price growth is supported by earnings growth, suggesting reasonable valuation relative to its profit expansion.

Over the past year, profits have surged by 136%, outpacing the stock’s 66.06% return, which highlights the company’s ability to convert operational success into bottom-line growth.

Sector and Market Context

Operating within the Pharmaceuticals & Biotechnology sector, Acutaas Chemicals Ltd has demonstrated market-beating performance both in the near term and over extended periods. Its ability to outperform the BSE500 index over one year, three months, and three years highlights its competitive positioning and resilience in a dynamic industry.

The company’s market capitalisation grade of 3 reflects a mid-tier valuation within its peer group, balancing growth potential with established market presence.

Summary of Key Performance Indicators

To summarise, Acutaas Chemicals Ltd’s recent all-time high price of Rs.2056.35 is supported by:

• Strong multi-year returns, including 356.83% over three years
• Consistent quarterly positive results over six consecutive quarters
• Robust financial metrics such as 21.30% ROCE and 5.74 times inventory turnover
• Debt-free capital structure with zero average Debt to Equity ratio
• High institutional ownership at 38.38%
• Recognition as a top-ranked stock by MarketsMojo with a Strong Buy grade

These factors collectively illustrate the company’s strong fundamentals and market performance that have culminated in this significant price milestone.

Conclusion

Acutaas Chemicals Ltd’s achievement of an all-time high price level is a testament to its sustained growth, financial discipline, and market leadership within the Pharmaceuticals & Biotechnology sector. The stock’s consistent outperformance relative to benchmarks and peers, combined with strong institutional support and solid financial ratios, underscores the company’s established position in the market as of early 2026.

Unlock special upgrade rates for a limited period. Start Saving Now →